Boston Scientific

Yahoo Finance • 10 hours ago

Wolfe Research cuts Boston Scientific rating as key growth drivers falter

Investing.com -- Wolfe Research downgraded Boston Scientific to Peer Perform in a note on Friday, declaring the end of a multiyear bullish thesis on the medical device company after its two key growth engines (pulsed field ablation and the... Full story

Yahoo Finance • 13 hours ago

Why Boston Scientific Stock Was Sliding This Week

Key Points Just after that, several analysts published new, bearish takes on the stock. One felt compelled to downgrade his recommendation on the medical device giant.10 stocks we like better than Boston Scientific › Boston Scientific(NY... Full story

Yahoo Finance • 2 days ago

Stocks Settle Mixed on Conflicting US-Iran Signals

The S&P 500 Index ($SPX) (SPY) on Wednesday closed up +0.02%, the Dow Jones Industrial Average ($DOWI) (DIA) closed up +0.36%, and the Nasdaq 100 Index ($IUXX) (QQQ) closed down -0.09%.  June E-mini S&P futures (ESM26) rose +0.04%, and Jun... Full story

Yahoo Finance • 2 days ago

US Equity Indexes Edge Higher as Crude Oil Slumps, Tech Giants Take Breather

US equity indexes ground higher amid a slump in crude oil prices as investors parsed ongoing talks t PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premiu... Full story

Yahoo Finance • 2 days ago

US Equity Markets Higher After Drop in Crude Oil Prices

US equity indexes were higher on Wednesday after a decline in crude oil prices and government bond y PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premiu... Full story

Yahoo Finance • 2 days ago

Boston Scientific Is the Worst Performing S&P 500 Stock. Here’s Why.

The medical device maker flags a drop in stand-alone procedures for its Watchman heart implant, hitting its near-term growth forecast. Continue Reading... Full story

Yahoo Finance • 2 days ago

Stocks Mixed Awaiting Fresh Iran News

The S&P 500 Index ($SPX) (SPY) today is down -0.07%, the Dow Jones Industrial Average ($DOWI) (DIA) is up +0.54%, and the Nasdaq 100 Index ($IUXX) (QQQ) is down -0.44%.  June E-mini S&P futures (ESM26) are down -0.07%, and June E-mini Nasd... Full story

Yahoo Finance • 2 days ago

Top Midday Decliners

Zscaler (ZS) shares plunged 31% intraday after the company issued a fiscal Q4 revenue outlook that m PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premiu... Full story

Yahoo Finance • 2 days ago

US Equity Indexes Trade Mixed Amid Sharp Sell-Off in Crude Oil

US equity indexes traded mixed but were off session lows amid a sharp decline in crude oil prices an PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premiu... Full story

Yahoo Finance • 2 days ago

Top Midday Stories: White House Refutes Iran Report of Interim Peace Deal; Zscaler Shares Plunge After Fiscal Q4 Revenue Guidance Misses Estimates

The Dow Jones Industrial Average was up, while the S&P 500 and Nasdaq Composite were about flat in l PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premiu... Full story

Yahoo Finance • 3 days ago

Belo Sun Announces 2026 Shareholder Meeting Voting Results and Corporate Update

TORONTO, May 26, 2026 (GLOBE NEWSWIRE) -- Belo Sun Mining Corp. (“Belo Sun” or the “Company”) (TSX:BSX OTCQX:BSXGF) today is pleased to announce that each of the six individuals nominated for election as a director of Belo Sun at the Com... Full story

Yahoo Finance • 3 days ago

BofA Cuts PT on Boston Scientific Corporation (BSX) Over Worries for Medtech

Boston Scientific Corporation (NYSE:BSX) is one of the best medical stocks to invest in according to billionaires. BofA cut the price target on Boston Scientific Corporation (NYSE:BSX) to $68 from $105 on May 18, reaffirming a Buy rating o... Full story

Yahoo Finance • 6 days ago

What to Know About This Fund's $10 Million Nektar Bet Ahead of a Key Phase 3 Launch

On May 15, 2026, Prosight Management disclosed a buy of 180,367 shares of Nektar Therapeutics(NASDAQ:NKTR), an estimated $10.27 million trade based on quarterly average pricing. What happened According to a Securities and Exchange Commis... Full story

Yahoo Finance • 8 days ago

Paroxysmal Supraventricular Tachycardia Market Analysis Report 2026-2036, Profiles of Leading Players - Medtronic, Boston Scientific, Abbott Laboratories, Milestone Pharmaceuticals, Sanofi, Pfizer

Company Logo The global Paroxysmal Supraventricular Tachycardia (PSVT) market is set for significant growth, driven by advancements in diagnostics and treatment, and rising cardiovascular awareness. Key factors include a surge in cardiova... Full story

Yahoo Finance • 9 days ago

Boston Scientific Corporation (BSX) Fell Due to Weak Results

TCW Funds, an investment management firm, published its first-quarter 2026 investor letter for the 'TCW Concentrated Large Cap Growth Fund.' A copy of the letter is available to download here. The first quarter was marked by volatility in... Full story

Yahoo Finance • 9 days ago

How META Stock Rises To $1,000

Meta Platforms (META) trades at around $600 per share, reflecting a $1.5 trillion market capitalization and a trailing price-to-earnings ratio of around 22. This multiple sits below both the three-year average of 25 and the three-year peak... Full story

Yahoo Finance • 9 days ago

Baird Maintains Bullish View on Boston Scientific (BSX) Despite Lower Target

With a 5-year average revenue growth rate of 13.52%, Boston Scientific Corporation (NASDAQ:BSX) is included among the 11 Best Long Term US Stocks to Buy Right Now.Baird Maintains Bullish View on Boston Scientific (BSX) Despite Lower Target... Full story

Yahoo Finance • 10 days ago

Sector Update: Healthcare Stocks Rise Tuesday Afternoon

Healthcare stocks rose Tuesday afternoon, with the NYSE Healthcare Index adding 1.1% and the State S PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premiu... Full story

Yahoo Finance • 10 days ago

Boston Scientific’s SEISMIQ 4CE succeeds in trial for coronary artery disease

[Boston Scientific Offers To Buy Guidant For $25 Billion] Joe Raedle/Getty Images News Boston Scientific (BSX [https://seekingalpha.com/symbol/BSX]) announced on Tuesday that its SEISMIQ 4CE catheter, an intravascular lithotripsy device d... Full story

Yahoo Finance • 10 days ago

Boston Scientific: FRACTURE Trial Meets Pre-specified Safety, Effectiveness Endpoints

(RTTNews) - Boston Scientific (BSX) announced positive results from the FRACTURE Investigational Device Exemption trial evaluating the use of the SEISMIQ 4CE Coronary Intravascular Lithotripsy Catheter to treat patients with severely calci... Full story